Sanjay Mistry

Sanjay earned his PhD in Biochemical Pharmacology and MSc in Clinical Pharmacology from the University of Aberdeen, Scotland and his BSc in Applied Biology from Nottingham Trent University, UK. He has 3 issued patents, 23 pending applications and 19 peer reviewed publications. Sanjay enjoys sports, cooking, and travelling.

Vice President, Venture Investments New Company Creation for Johnson & Johnson Innovation – JJDC Inc. and is based La Jolla California.  His team focuses on investments that create companies based on internal or externally derived innovations that can deliver transformational healthcare solutions based on new growth platforms for JJIM and J&J Med-Tech. He is currently on the Boards of Rapport Therapeutics (Director), TRex Bio (Director) and Manifest Technologies (Observer).  Other past company creations include Provention Bio (Acquired by Sanofi), Fusion Pharmaceuticals (Acquired by Astrazeneca) & Aro Therapeutics (Private). 

Sanjay also spent 5 years as an investor with healthcare venture capital firm Quaker Partners, where he focused on biopharmaceuticals and diagnostic/tools investing. Key investments included Durata Therapeutics (Acquired by Actavis), RainDance Technologies (Acquired by BioRad) & Rapid Micro Biosystems (Public - RPID).

Prior to joining JJDC he held several roles across J&J including being the Head of JLABS @ San Diego, Senior Finance Director Business Operations for Janssen R&D & a Co-founder of an internal venture at Centocor which developed a Phase 2b ready cell therapy for age related macular degeneration. Prior to this he was an entrepreneur at Morphogen Pharmaceuticals, where he led pre-clinical development of cell therapies for cardiovascular and neurological indications. 

Sanjay attained a PhD in Pharmacology & MSc. in Clinical Pharmacology from the University of Aberdeen and a BSc. in Biomedical Sciences/Pharmacology from Nottingham Trent University. He has 20 peer reviewed publications, 40US/160 foreign issued patents and is a Kauffman Life Science Fellow (Class 14).

Sanjay is a member of Class 14 and served his fellowship at Quaker BioVentures under mentor Adele Oliva, a member of Fellows Class 2.